U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Seasonal affective disorder: Do non-drug interventions such as light and vitamin therapy lead to better results? IQWiG Reports – Commission No. HT18-04 [Internet] Cologne (Germany): Institute for Quality and Efficiency in Health Care (IQWiG); 2021 Apr 14.

Cover of Seasonal affective disorder

Seasonal affective disorder: Do non-drug interventions such as light and vitamin therapy lead to better results? IQWiG Reports – Commission No. HT18-04 [Internet]

Show details

References

Please see full HTA report for the full reference list.

1.
Rosenthal NE, Sack DA, Gillin J, et al. Seasonal affective disorder: a description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry 1984; 41(1): 72-80. [PubMed: 6581756]
2.
World Health Organization. The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. Geneva, Switzerland: World Health Organization; 1993.
3.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association; 2013.
4.
Tam EM, Lam RW, Robertson HA, Stewart JN, Yatham LN, Zis AP. Atypical depressive symptoms in seasonal and non-seasonal mood disorders. J Affect Disord 1997; 44(1): 39-44. [PubMed: 9186801]
5.
Partonen T, Rosenthal N. Diagnostic assessment. In: Partonen T, Pandi-Perumal SR. (Ed). Seasonal affective disorder practice and research. New York: Oxford University Press; 2010. p. 247-254.
6.
Rastad C, Wetterberg L, Martin C. Patients’ experience of winter depression and light room treatment. Psychiatry J 2017; 2017: 6867957. [PMC free article: PMC5331315] [PubMed: 28293623]
7.
Wirz-Justice A, Graw P, Krauchi K, Wacker HR. Seasonality in affective disorders in Switzerland. Acta Psychiatr Scand Suppl 2003; (418): 92-95. [PubMed: 12956822]
8.
Pjrek E, Baldinger-Melich P, Spies M, Papageorgiou K, Kasper S, Winkler D. Epidemiology and socioeconomic impact of seasonal affective disorder in Austria. Eur Psychiatry 2016; 32:28-33. [PubMed: 26802981]
9.
Schwartz PJ, Brown C, Wehr TA, Rosenthal NE. Winter seasonal affective disorder: a follow-up study of the first 59 patients of the National Institute of Mental Health Seasonal Studies Program. Am J Psychiatry 1996; 153(8): 1028-1036. [PubMed: 8678171]
10.
Magnusson A, Partonen T. The diagnosis, symptomatology, and epidemiology of seasonal affective disorder. CNS Spectr 2005; 10(8): 625-634. [PubMed: 16041294]
11.
Levitan RD. The chronobiology and neurobiology of winter seasonal affective disorder. Dialogues Clin Neurosci 2007; 9(3): 315-324. [PMC free article: PMC3202491] [PubMed: 17969868]
12.
Rimaldi S, Partonen T. Self-care options. In: Partonen T, Pandi-Perumal SR. (Ed). Seasonal affective disorder practice and research. New York: Oxford University Press; 2010. p. 321-329.
13.
DGPPN, BÄK, KBV, AWMF, AKDÄ, BPTKet al. S3-Leitlinie/Nationale VersorgungsLeitlinie: Unipolare Depression; Langfassung. Deutschland: DGPPN BÄK KBV AWMF AdkÄ BPtK BApK DAGSHG DEGAM DGPM DGPs DGRW für die Leitliniengruppe Unipolare Depression; 2015.
14.
Terman M, Terman JS. Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects. CNS Spectr 2005; 10(8): -; quiz 672. [PubMed: 16041296]
15.
Levitan RD. What is the optimal implementation of bright light therapy for seasonal affective disorder (SAD)? J Psychiatry Neurosci 2005; 30(1): 72-72. [PMC free article: PMC543845] [PubMed: 15645001]
16.
Pail G, Huf W, Pjrek E, Winkler D, Willeit M, Praschak-Rieder N, et al. Bright-light therapy in the treatment of mood disorders. Neuropsychobiology 2011; 64(3): 152-162. [PubMed: 21811085]
17.
Danilenko KV, Ivanova IA. Dawn simulation vs. bright light in seasonal affective disorder: treatment effects and subjective preference. J Affect Disord 2015; 180: 87-89. [PubMed: 25885065]
18.
Terman M, Schlager D, Fairhurst S, Perlman B. Dawn and dusk simulation as a therapeutic intervention. Biol Psychiatry 1989; 25(7): 966-970. [PubMed: 2720008]
19.
Avery D, Bolte MA, Millet M. Bright dawn simulation compared with bright morning light in the treatment of winter depression. Acta Psychiatr Scand 1992; 85(6): 430-434. [PubMed: 1642124]
20.
Lingjaerde O, Foreland AR, Dankertsen J. Dawn simulation vs. lightbox treatment in winter depression: a comparative study. Acta Psychiatr Scand 1998; 98(1): 73-80. [PubMed: 9696518]
21.
Gloth FM 3rd, Alam W, Hollis B. Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. J Nutr Health Aging 1999; 3(1): 5-7. [PubMed: 10888476]
22.
Neumeister A, Konstantinidis A, Praschak-Rieder N, Willeit M, Hilger E, Stastny J, et al. Monoaminergic function in the pathogenesis of seasonal affective disorder. Int J Neuropsychopharmacol 2001; 4(4): 409-420. [PubMed: 11806867]
23.
Thaler K, Delivuk M, Chapman A, Gaynes BN, Kaminski A, Gartlehner G. Second-generation antidepressants for seasonal affective disorder. Cochrane Database Syst Rev 2011; (12): CD008591. [PubMed: 22161433]
24.
Young M, Yap B. Psychological and biological traits in seasonal affective disorder and seasonality. In: Partonen T, Pandi-Perumal SR. (Ed). Seasonal affective disorder practice and research. New York: Oxford University Press; 2010. p. 189-208..
25.
Rohan KJ, Meyerhoff J, Ho SY, Evans M, Postolache TT, Vacek PM. Outcomes one and two winters following cognitive-behavioral therapy or light therapy for seasonal affective disorder. Am J Psychiatry 2016; 173(3): 244-251. [PMC free article: PMC4939843] [PubMed: 26539881]
26.
Gemeinsamer Bundesausschuss (G-BA). Richtlinie des Gemeinsamen Bundesausschusses über die Durchführung der Psychotherapie [online]. 16.02.2017 [Accessed: 12.11.2018]. URL: https://www​.g-ba.de/downloads​/62-492-1266​/PT-RL_2016-11-24_iK-2017-02-16.pdf.
27.
Gemeinsamer Bundesausschuss (G-BA). Systemische Therapie: Anerkennung des Nutzens und der medizinischen Notwendigkeit als Psychotherapieverfahren [online]. 22.11.2018 [Accessed: 04.12.2018]. URL: https://www​.g-ba.de/informationen​/beschluesse/3588/.
28.
Nussbaumer-Streit B, Winkler D, Spies M, Kasper S, Pjrek E. Prevention of seasonal affective disorder in daily clinical practice: results of a survey in German-speaking countries. BMC Psychiatry 2017; 17(1): 247. [PMC free article: PMC5504611] [PubMed: 28693583]
29.
Golden RN, Gaynes BN, Ekstrom RD, Hamer RM, Jacobsen FM, Suppes T, et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry 2005; 162(4): 656-662. [PubMed: 15800134]
30.
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. [GA17-01] Steigerung der Effizienz der Studienselektion [online]. [Accessed: 12.09.2018]. URL: https://www​.iqwig.de​/de/projekte-ergebnisse​/projekte/institutsleitung​/ga17-01-steigerung-der-effizienz-der-studienselektion.7847.html.
31.
Schwarzer G. Meta: an R package for meta-analysis. R News 2007; 7(3): 40-45.
32.
Rücker G, Krahn U, König J, Efthimiou O, Schwarzer G. Netmeta: network meta-analysis using frequentist methods. 2019.
33.
R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2019.
34.
Statistisches Bundesamt. Harmonisierter Verbraucherpreisindex (inkl. Veränderungsraten) [online]. [Accessed: 17.05.2019]. URL: https://www-genesis​.destatis​.de/genesis/online.
35.
Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 2015.
36.
The World Bank. World Bank country and lending groups [online]. [Accessed: 22.01.2018]. URL: https:​//datahelpdesk​.worldbank.org/knowledgebase​/articles/906519-world-bank-country-and-lending-groups.
37.
Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Int J Technol Assess Health Care 2013; 29(2): 117-122. [PubMed: 23587340]
38.
International Society for Pharmacoeconomics and Outcomes Research. Assessing the evidence for health care decision makers [online]. [Accessed: 05.11.2018]. URL: https://www​.healthstudyassessment.org/.
39.
European Network for Health Technology Assessment. EUnetHTA HTA adaptation toolkit: work package 5; version 5 [online]. 10.2011 [Accessed: 06.08.2018]. URL: https://www​.eunethta​.eu/wp-content/uploads​/2011/01/EUnetHTA_adptation​_toolkit_2011_version_5.pdf.
40.
Hofmann B, Droste S, Oortwijn W, Cleemput I, Sacchini D. Harmonization of ethics in health technology assessment: a revision of the Socratic approach. Int J Technol Assess Health Care 2014; 30(1): 3-9. [PubMed: 24499630]
41.
Lysdahl KB, Mozygemba K, Chilcott JB, Brönneke JB, Hofmann Be. Guidance for assessing effectiveness, economic aspects, ethical aspects, socio-cultural aspects and legal aspects in compley technologies [online]. URL: https://www​.integrate-hta.eu/downloads/.
42.
Mozygemba K, Hofmann B, Bakke Lysdal K, Pfadenhauer L, Van der Wilt G, Gerhardus A. Guidance to assess socio-cultural aspects [online]. In: Lysdahl KB, Mozygemba K, Burns L, Chilcott JB, Brönneke JB, Hofmann B. (Ed). Guidance for assessing effectiveness, economic aspects, ehtical aspects, socio-cultural aspects and legal aspects in complex technologies. 01.02.2016 [Accessed: 06.08.2018]. URL: http://www​.integrate-hta​.eu/wp-content/uploads​/2016/08/IPP_Guidance-INTEGRATE-HTA_Nr.3_FINAL.pdf.
43.
Perleth M, Gibis B, Velasco Garrido M, Zentner A. Organisationsstrukturen und Qualität. In: Perleth M, Busse R, Gerhardus A, Gibis B, Zentner A. (Ed). Health Technology Assessment: Konzepte, Methoden, Praxis für Wissenschaft und Entscheidungsfindung. Berlin: Medizinisch Wissenschaftliche Verlagsgesellschaft; 2014. p. 265-279.
44.
Brönneke JB, Hofmann B, Bakke Lysdal K, Van der Wilt G, Buchner B. Guidance to assess legal aspects [online]. In: Lysdahl KB, Mozygemba K, Burns L, Chilcott JB, Brönneke JB, Hofmann B. (Ed). Guidance for assessing effectiveness, economic aspects, ehtical aspects, socio-cultural aspects and legal aspects in complex technologies. 01.02.2016 [Accessed: 06.08.2018]. URL: http://www​.integrate-hta​.eu/wp-content/uploads​/2016/08/IPP_Guidance-INTEGRATE-HTA_Nr.3_FINAL.pdf.
45.
Anderson JL, Glod CA, Dai J, Cao Y, Lockley SW. Lux vs. wavelength in light treatment of seasonal affective disorder. Acta Psychiatr Scand 2009; 120(3): 203-212. [PubMed: 19207131]
46.
Avery DH, Eder DN, Bolte MA, Hellekson CJ, Dunner DL, Vitiello MV, et al. Dawn simulation and bright light in the treatment of SAD: a controlled study. Biol Psychiatry 2001; 50(3): 205-216. [PubMed: 11513820]
47.
Desan PH, Weinstein AJ, Michalak EE, Tam EM, Meesters Y, Ruiter MJ, et al. A controlled trial of the Litebook light-emitting diode (LED) light therapy device for treatment of seasonal affective disorder (SAD). BMC Psychiatry 2007; 7: 38. [PMC free article: PMC1971065] [PubMed: 17683643]
48.
Yale University. Environmental treatment for seasonal affective disorder (SAD): study results [online]. In: ClinicalTrials.gov. 06.03.2013 [Accessed: 07.03.2019]. URL: https:​//clinicaltrials​.gov/ct2/show/results/NCT00139997.
49.
Eastman CI, Lahmeyer HW, Watell LG, Good GD, Young MA. A placebo-controlled trial of light treatment for winter depression. J Affect Disord 1992; 26(4): 211-221. [PubMed: 1479133]
50.
Eastman CI, Young MA, Fogg LF, Liu L, Meaden PM. Bright light treatment of winter depression: a placebo-controlled trial. Arch Gen Psychiatry 1998; 55(10): 883-889. [PubMed: 9783558]
51.
Glickman G, Byrne B, Pineda C, Hauck WW, Brainard GC. Light therapy for seasonal affective disorder with blue narrow-band light-emitting diodes (LEDs). Biol Psychiatry 2006; 59(6): 502-507. [PubMed: 16165105]
52.
Joffe RT, Moul DE, Lam RW, Levitt AJ, Teicher MH, Lebegue B, et al. Light visor treatment for seasonal affective disorder: a multicenter study. Psychiatry Res 1993; 46(1): 29-39. [PubMed: 8464953]
53.
Levitt AJ, Joffe RT, Moul DE, Lam RW, Teicher MH, Lebegue B, et al. Side effects of light therapy in seasonal affective disorder. Am J Psychiatry 1993; 150(4): 650-652. [PubMed: 8465886]
54.
Lam RW, Levitt AJ, Levitan RD, Enns MW, Morehouse R, Michalak EE, et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. Am J Psychiatry 2006; 163(5): 805-812. [PubMed: 16648320]
55.
Michalak EE, Murray G, Levitt AJ, Levitan RD, Enns MW, Morehouse R, et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the Can-SAD study. Psychol Med 2007; 37(5): 727-736. [PubMed: 17112403]
56.
Levitt AJ, Joffe RT, King E. Dim versus bright red (light-emitting diode) light in the treatment of seasonal affective disorder. Acta Psychiatr Scand 1994; 89(5): 341-345. [PubMed: 8067273]
57.
Levitt AJ, Wesson VA, Joffe RT, Maunder RG, King EF. A controlled comparison of light box and head-mounted units in the treatment of seasonal depression. J Clin Psychiatry 1996; 57(3): 105-110. [PubMed: 8617693]
58.
Michalon M, Eskes GA, Mate-Kole CC. Effects of light therapy on neuropsychological function and mood in seasonal affective disorder. J Psychiatry Neurosci 1997; 22(1): 19-28. [PMC free article: PMC1188813] [PubMed: 9002389]
59.
Rohan KJ, Lindsey KT, Roecklein KA, Lacy TJ. Cognitive-behavioral therapy, light therapy, and their combination in treating seasonal affective disorder. J Affect Disord 2004; 80(2-3): 273-283. [PubMed: 15207942]
60.
Rohan KJ, Roecklein KA, Tierney Lindsey K, Johnson LG, Lippy RD, Lacy TJ, et al. A randomized controlled trial of cognitive-behavioral therapy, light therapy, and their combination for seasonal affective disorder. J Consult Clin Psychol 2007; 75(3): 489-500. [PubMed: 17563165]
61.
Henry M. Jackson Foundation for the Advancement of Military Medicine. cognitive behavioral therapy for the treatment of seasonal affective disorder (SAD): study details [online]. In: ClinicalTrials.gov. 25.06.2014 [Accessed: 07.03.2019]. URL: https:​//clinicaltrials​.gov/ct2/show/NCT00076245.
62.
Rohan KJ, Mahon JN, Evans M, Ho SY, Meyerhoff J, Postolache TT, et al. Randomized trial of cognitive-behavioral therapy versus light therapy for seasonal affective disorder: acute outcomes. Am J Psychiatry 2015; 172(9): 862-869. [PMC free article: PMC7962797] [PubMed: 25859764]
63.
Rohan KJ, Evans M, Mahon JN, Sitnikov L, Ho SY, Nillni YI, et al. Cognitive-behavioral therapy vs. light therapy for preventing winter depression recurrence: study protocol for a randomized controlled trial. Trials 2013; 14: 82. [PMC free article: PMC3652773] [PubMed: 23514124]
64.
Rohan KJ, Meyerhoff J, Ho SY, Evans M, Postolache TT, Vacek PM. Outcomes one and two winters following cognitive-behavioral therapy or light therapy for seasonal affective disorder. Am J Psychiatry 2016; 173(3): 244-251. [PMC free article: PMC4939843] [PubMed: 26539881]
65.
University of Vermont. Cognitive-behavioral therapy vs. light therapy for preventing SAD recurrence: study details [online]. In: ClinicalTrials.gov. 26.02.2014 [Accessed: 07.03.2019]. URL: https:​//clinicaltrials​.gov/ct2/show/NCT01714050.
66.
Ruhrmann S, Kasper S, Hawellek B, Martinez B, Hoflich G, Nickelsen T, et al. Effects of fluoxetine versus bright light in the treatment of seasonal affective disorder. Psychol Med 1998; 28(4): 923-933. [PubMed: 9723147]
67.
Spezzano Mark A. The efficacy of bright light treatment on the symptoms of seasonal affective disorder on a college-aged population. Diss Abstr Int 2007; 67(9-b): 5423.
68.
Spies M, James GM, Vraka C, Philippe C, Hienert M, Gryglewski G, et al. Brain monoamine oxidase A in seasonal affective disorder and treatment with bright light therapy. Transl Psychiatry 2018; 8(1): 198. [PMC free article: PMC6155094] [PubMed: 30242221]
69.
Medical University of Vienna. Influence of light exposure on cerebral MAO-A in seasonal affective disorder and healthy controls measured by PET: study details [online]. In: ClinicalTrials.gov. 05.05.2018 [Accessed: 07.03.2019]. URL: https:​//clinicaltrials​.gov/ct2/show/NCT02582398.
70.
Teicher MH, Glod CA, Oren DA, Schwartz PJ, Luetke C, Brown C, et al. The phototherapy light visor: more to it than meets the eye. Am J Psychiatry 1995; 152(8): 1197-1202. [PubMed: 7625470]
71.
Terman M, Terman JS. Controlled trial of naturalistic dawn simulation and negative air ionization for seasonal affective disorder. [Erratum appears in Am J Psychiatry. 2007 Mar;164(3):529]. Am J Psychiatry 2006; 163(12): 2126-2133. [PubMed: 17151164]
72.
Wileman SM, Eagles JM, Andrew JE, Howie FL, Cameron IM, McCormack K, et al. Light therapy for seasonal affective disorder in primary care: randomised controlled trial. Br J Psychiatry 2001; 178: 311-316. [PubMed: 11282809]
73.
Yale University. A trial of negative ion generation versus light-emitting diode phototherapy for seasonal affective disorder (SAD): study results [online]. In: ClinicalTrials.gov. March 6, 2013 [Accessed: 07.03.2019]. URL: https:​//clinicaltrials​.gov/ct2/show/results/NCT00809523.
74.
Universitätsmedizin der Johannes-Gutenberg-Universität Mainz. Lichttherapie [online]. [Accessed: 17.05.2019]. URL: http://www​.unimedizin-mainz​.de/psychiatrie​/patienten/weitere-behandlungsangebote/lichttherapie.html.
75.
Bundesministerium der Justiz und für Verbraucherschutz - Gesetze im Internet. Sozialgesetzbuch (SGB) Fünftes Buch (V) - Gesetzliche Krankenversicherung - (Artikel 1 des Gesetzes v. 20. Dezember 1988, BGBl. I S. 2477) § 61 Zuzahlungen [online]. [Accessed: 18.05.2019]. URL: https://www​.gesetze-im-internet​.de/sgb_5/__61.html.
76.
Gemeinsamer Bundesausschuss (G-BA). Richtlinie über die Verordnung von Heilmitteln in der vertragsärztlichen Versorgung - Heilmittel-Richtlinie/HeilM-RL [online]. Letzte Änderung: 21.09.2017 BAnz AT 23.11.2017 B1, In Kraft getreten am: 01.01.2018 [Accessed: 16.05.2019]. URL: https://www​.g-ba.de/downloads​/62-492-1484​/HeilM-RL_2017-09-21_iK-2018-01-01.pdf.
77.
MediSana GmbH. Lichttherapie-Lampen [online]. [Accessed: 13.05.2019]. URL: https://www​.medisana​.de/Therapieprodukte​/Lichttherapie-Lampen​/Tageslichtlampen-Lichtduschen/.
78.
Beurer GmbH. Tageslichtlampen [online]. [Accessed: 13.05.2019]. URL: https://www​.beurer.com​/web/de/produkte/wellbeing​/lichttherapie/tageslichtlampen/.
79.
mhplus Krankenkasse. Lichttherapie: Anwendungsgebiete und Wirkungsweisen. [online]. [Accessed: 13.05.2019]. URL: https://www​.mhplus-krankenkasse​.de/privatkunden​/gesundheits_leistungen​/versorgung_plus​/psychische_erkrankungen​/lichttherapie/.
80.
Gemeinsamer Bundesausschuss (G-BA). Arzneimittelrichtlinie des G-BA, Anlage I: OTC-Übersicht [online]. [Accessed: 12.06.2019]. URL: https://www​.g-ba.de/richtlinien​/anlage/17/.
81.
Huhn Maximilian. Korrespondenz zu Interventionskosten bzw. Klinischem Behandlungsablauf am 23.05., 22.06., 24.06., 28.06.2019. 2019.
82.
Praschak-Rieder N, Willeit M. Treatment of seasonal affective disorders. Dialogues Clin Neurosci 2003; 5(4): 389-398. [PMC free article: PMC3181778] [PubMed: 22033639]
83.
Avery D. Seasonal affective disorder: treatment [online]. In: UpToDate. 09.11.2017 [Accessed: 20.05.2019]. URL: https://www​.uptodate​.com/contents/seasonal-affective-disorder-treatment.
84.
Ross LM. Cost-benefit and cost-utility analyses of cognitive-behavioral therapy versus light therapy for seasonal affective disorder [Dissertation]. Washington, D.C.: American University; 2017 URL: http://hdl​.handle.net​/1961/auislandora:68591.
85.
Freed MC. Costs and cost-effectiveness of seasonal affective disorder treatment: comparing light therapy, group cognitive-behavioral therapy, and their combination [Dissertation]. Washington, D.C.: American University; 2005. URL: http://hdl​.handle.net​/1961/thesesdissertations:3193.
86.
Walbert H. With IGeL (individual health allowance) against winter blues. MMW Fortschr Med 2009; 151(45): 11. [PubMed: 19960714]
87.
Cheung A, Dewa C, Michalak EE, Browne G, Levitt A, Levitan RD, et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Research and Treatment 2012; 2012: 628434. [PMC free article: PMC3483827] [PubMed: 23119154]
88.
Freed MC, Rohan KJ, Yates BT. Estimating health utilities and quality adjusted life years in seasonal affective disorder research. J Affect Disord 2007; 100(1-3): 83-89. [PubMed: 17084462]
89.
Rohan KJ, Mahon JN, Evans M, Ho SY, Meyerhoff J, Postolache TT, et al. Randomized trial of cognitive-behavioral therapy versus light therapy for seasonal affective disorder: acute outcomes. Am J Psychiatry 2015; 172(9): 862-869. [PMC free article: PMC7962797] [PubMed: 25859764]
90.
Drummond M, Sculpher M. Common methodological flaws in economic evaluations. Med Care 2005; 43(7): II5-II14. [PubMed: 16056003]
91.
Revicki DA, Wood M. Patient-assigned health state utilities for depression-related outcomes: differences by depression severity and antidepressant medications. J Affect Disord 1998; 48(1): 25-36. [PubMed: 9495599]
92.
Kolovos S, Bosmans JE, van Dongen JM, van Esveld B, Magai D, Van Straten A, et al. Utility scores for different health states related to depression: individual participant data analysis. Qual Life Res 2017; 26(7): 1649-1658. [PMC free article: PMC5486895] [PubMed: 28260149]
93.
nstitute for Quality and Efficiency in Health Care. General methods: version 5.0 [online]. 10.07.2017 [Accessed: 06.08.2020]. URL: https://www​.iqwig.de​/download/General-Methods_Version-5-0​.pdf.
94.
Antonuccio DO, Thomas M, Danton WG. A cost-effectiveness analysis of cognitive behavior therapy and fluoxetine (prozac) in the treatment of depression. Behav Ther 1997; 28(2): 187-210.
95.
Sturm R. Economic grand rounds: the myth of medical cost offset. Psychiatr Serv 2001; 52(6): 738-740. [PubMed: 11376220]
96.
Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 1992; 146(4): 473-481. [PMC free article: PMC1488412] [PubMed: 1306034]
97.
Winkler D, Praschak-Rieder N, Willeit M, Lucht MJ, Hilger E, Konstantinidis A, et al. Seasonal affective depression in 2 German speaking university centers: Bonn, Vienna; clinical and demographic characteristics. Nervenarzt 2002; 73(7): 637-643. [PubMed: 12212526]
98.
Wallin MS, Rissanen AM. Food and mood: relationship between food, serotonin and affective disorders. Acta Psychiatr Scand Suppl 1994; 377: 36-40. [PubMed: 8053364]
99.
European Depression Association. Depression manifesto [online]. [Accessed: 09.04.2019]. URL: http://eddas​.eu/wp-content​/uploads/2016/04​/DepressionManifesto_01_04.pdf.
100.
Preston J. Pharmacologie treatment of depression. J Fam Psychother 2007; 17(3-4): 35-52.
101.
Kemp DE, Malhotra S, Franco KN, Tesar G, Bronson DL. Heart disease and depression: don’t ignore the relationship. Cleve Clin J Med 2003; 70(9): 745-761. [PubMed: 14518570]
102.
Martin MW. Depression and Identity. In: Martin MW, editor. (Ed). From morality to mental health: virtue and vice in a therapeutic culture. New York: Oxford University Press; 2006. URL: https://oxford​.universitypressscholarship​.com/view/10.1093/0195304713​.001.0001/acprof-9780195304718-chapter-12.
103.
Winkler D, Pjrek E, Spies M, Willeit M, Dorffner G, Lanzenberger R, et al. Has the existence of seasonal affective disorder been disproven? J Affect Disord 2017; 208(C): 54-55. [PubMed: 27744127]
104.
Nussbaumer-Streit B, Pjrek E, Kien C, Gartlehner G, Bartova L, Friedrich M-E, et al. Implementing prevention of seasonal affective disorder from patients’ and physicians’ perspectives: a qualitative study. BMC Psychiatry 2018; 18(1): 372-372. [PMC free article: PMC6260561] [PubMed: 30477472]
105.
Kramer P. Listening to Prozac. New York: Penguin; 1997.
106.
Hodge DR, Bonifas RP. Using spiritually modified cognitive behavioral therapy to help clients wrestling with depression: a promising intervention for some older adults. J Relig Spiritual Soc Work 2010; 29(3): 185-206.
107.
Yokoya S, Maeno T, Sakamoto N, Goto R, Maeno T. A brief survey of public knowledge and stigma towards depression. J Clin Med Res 2018; 10(3): 202-209. [PMC free article: PMC5798266] [PubMed: 29416578]
108.
Cassell EJ. Recognizing suffering. Hastings Cent Rep 1991; 21(3): 24-24. [PubMed: 1885294]
109.
Bund für Lebensmittelrecht und Lebensmittelkunde. Markt für Nahrungsergänzungsmittel in Deutschland 2018 [online]. URL: https://www​.bll.de/de​/der-bll/organisation​/arbeitskreise/arbeitskreis-nahrungsergaenzungsmittel-ak-nem​/20181029-zahlen-nahrungsergaenzungsmittel-markt-2018.
110.
Cochran WG. The combination of estimates from different experiments. Biometrics 1954; 10(1): 101-129.
111.
Meesters Y, Gordijn MC. Seasonal affective disorder, winter type: current insights and treatment options. Psychol Res Behav Manag 2016; 9: 317-327. [PMC free article: PMC5138072] [PubMed: 27942239]
112.
Bürgerliches Gesetzbuch (BGB) [online]. 20.11.2019 [Accessed: 02.12.2019]. URL: https://www​.gesetze-im-internet​.de/bgb/BJNR001950896.html.
113.
Strafgesetzbuch (StGB) [online]. [Accessed: 02.12.2019]. URL: https://www​.gesetze-im-internet​.de/stgb/index.html.
114.
Europäisches Parlament, Europäischer Rat. Richtlinie 93/42/EWG des Rates [online]. 11.10.2007 [Accessed: 02.12.2019]. URL: https://eur-lex​.europa​.eu/legal-content/DE​/TXT/PDF/?uri=CELEX​:01993L0042-20071011&from=DE.
115.
Bundesamt für Verbraucherschutz und Lebensmittelsicherheit, Bundesinstitut für Arzneimittel und Medizinprodukte. Gemeinsame Expertenkommission zur Einstufung von Stoffen Stellungnahme zu Vitamin-D-haltigen Produkten (01/2016): Revision 1.1 (2017) [online]. 16.02.2017 [Accessed: 01.07.2019]. URL: https://www​.bvl.bund​.de/SharedDocs/Downloads​/01_Lebensmittel​/expertenkommission/Zweite​_Stellungnahme_VitaminD_Revision1​.1​.pdf;jsessionid=6ED031A6CDEF9AD1F83883275912EF15​.2_cid340?__blob​=publicationFile&v=2.
116.
Verordnung über diätetische Lebensmittel (Diätverordnung DiätV) in der Fassung der Bekanntmachung vom 28.04.2005 (BGBl. I S 1161), die zuletzt durch Artikel 60 der Verordnung vom 31.08.2015 (BGBl. I S 1474) geändert worden ist, [online]. [Accessed: 02.12.2019]. URL: http://extwprlegs1​.fao​.org/docs/pdf/ger89197.pdf.
117.
Spickhoff A, editor. (Ed). Medizinrecht3. München: C.H.Beck; 2018.
118.
BVL/BfArM. Gemeinsame Expertenkommission zur Einstufung von Stoffen. 2017. (Stellungnahme zu Vitamin-D-haltigen Produkten).
119.
Menculini G, Verdolini N, Murru A, Pacchiarotti I, Volpe U, Cervino A, et al. Depressive mood and circadian rhythms disturbances as outcomes of seasonal affective disorder treatment: a systematic review. J Affect Disord 2018; 241: 608-626. [PubMed: 30172213]
120.
Martensson B, Pettersson A, Berglund L, Ekselius L. Bright white light therapy in depression: a critical review of the evidence. J Affect Disord 2015; 182: 1-7. [PubMed: 25942575]
121.
Brouwer A, Nguyen H, Snoek F, van Raalte D, Beekman A, Moll A, et al. Light therapy: is it safe for the eyes? Acta Psychiatr Scand 2017; 136(6): 534-548. [PubMed: 28891192]
122.
Parker GB, Brotchie H, Graham RK. Vitamin D and depression. J Affect Disord 2017; 208: 56-61. [PubMed: 27750060]
123.
National Institute for Health and Care Excellence. Depression in adults: recognition and management [online]. 28.10.2009 [Accessed: 20.08.2019]. (Clinical guidelines; Volume 90). URL: https://www​.nice.org​.uk/guidance/cg90/resources​/depression-in-adults-recognition-and-management-pdf-975742636741. [PubMed: 31990491]
124.
Leucht S, Fennema H, Engel RR, Kaspers-Janssen M, Lepping P, Szegedi A. What does the MADRS mean? Equipercentile linking with the CGI using a company database of mirtazapine studies. J Affect Disord 2017; 210: 287-293. [PubMed: 28068617]
125.
Leucht S, Fennema H, Engel R, Kaspers-Janssen M, Lepping P, Szegedi A. What does the HAMD mean? J Affect Disord 2013; 148(2-3): 243-248. [PubMed: 23357658]
126.
European Network for Health Technology Assessment. EUnetHTA Joint Action 2: work package 8; HTA core model; version 3.0 [online]. 25.01.2016 [Accessed: 06.08.2018]. URL: https://meka​.thl.fi/htacore​/model/HTACoreModel3.0.pdf.
127.
Wong SSL, Wilczynski NL, Haynes RB. Comparison of top-performing search strategies for detecting clinically sound treatment studies and systematic reviews in MEDLINE and EMBASE. J Med Libr Assoc 2006; 94(4): 451-455. [PMC free article: PMC1629423] [PubMed: 17082841]
128.
Lefebvre C, Manheimer E, Glanville J. Searching for studies [online]. In: Higgings JPT, Green S. (Ed). Cochrane handbook for systematic reviews of interventions: version 5.1.0. 03.2011 [Accessed: 05.09.2018]. URL: http://handbook-5-1​.cochrane​.org/chapter_6​/6_searching_for_studies.htm.
129.
Glanville J, Fleetwood K, Yellowlees A, Kaunelis D, Mensinkai S. Development and testing of search filters to identify economic evaluations in MEDLINE and EMBASE. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2009. URL: http://www​.cadth.ca/media​/pdf/H0490_Search​_Filters_for_Economic​_Evaluations_mg_e.pdf.
130.
Eady AM, Wilczynski NL, Haynes RB. PsycINFO search strategies identified methodologically sound therapy studies and review articles for use by clinicians and researchers. J Clin Epidemiol 2008; 61(1): 34-40. [PMC free article: PMC2254323] [PubMed: 18083460]

The full HTA report (German version) is published under

https://www.iqwig.de/sich-einbringen/themencheck-medizin-thema-vorschlagen/hta-berichte/ht18-04.html

© IQWiG (Institute for Quality and Efficiency in Health Care)
Bookshelf ID: NBK569934
Contents

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (811K)

Other titles in this collection

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

ClearTurn OffTurn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...